hotspot -WSS

hotspot

author：leisure time 2025-08-04 04:17:54 - browse：93

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Study on Amgen’s bispecific immunotherapy produces positive data

focus

WSS

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Goldman Sachs launches $650M fund for life science investments

Roivant's CEO is a star, but biotech's black hole persists

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

CZI to create biohub to build anti

explore

hotspot

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

U.K. sequencing study surfaces new findings about tumor DNA

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cassava Sciences’ Alzheimer’s clinical trials should be halted

BioMarin wins approval for gene therapy to treat hemophilia A

How a scoliosis diagnosis changed the life of one young dancer

Alkermes shareholders re

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Alkermes shareholders re

ADCs take center stage as promising cancer treatments

Wikipedia

3 medical device trends to watch in 2024

GSK Flovent asthma inhalers replaced by authorized generics

UCB departs biotech trade group BIO

GSK Flovent asthma inhalers replaced by authorized generics

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

J&J lung cancer data amount to new salvo against AstraZeneca

knowledge

entertainment

focus

focus